side effects to bpc 157 BPC-157 for athletes and injury treatment: Science, safety, and legal concerns FDA panel votes to ease

Statement on unapproved peptide drug substances and FDA review

BPC-157 is one of the most extensively studied peptides in preclinical literature, with a research history spanning over three decades

Unlike many endogenous peptides that degrade rapidly in the gastrointestinal tract, BPC-157 exhibits unusual stability, making it a robust subject for in vitro and in vivo laboratory investigations

While no evidence directly links BPC-157 to cancer development or progression, individuals with cancer history, undiagnosed masses, or strong family history of aggressive cancers should exercise caution

These molecular signals trigger cascading cellular responses that continue independently after the peptide itself has been metabolized